© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 15, 2020
July 08, 2020
Those who received the agent in EMERGE reported a significant slowing of decline on measures of cognition and function such as memory, orientation, and language, as well as for activities of daily living.
Tests for N-methyl-Daspartate receptor, myelin oligodendrocyte glycoprotein, and aquaporin-4 autoantibodies had negative results in all patients.
July 03, 2020
The results echo the previous understanding of MS specialists as well as add to the literature that has been collected thus far from other assessments.